Swine flu vaccine and multiple sclerosis

JAMA
|May 25, 1984
PubMed

Insights

The 1976 swine flu vaccine did not increase the risk of developing multiple sclerosis (MS). Studies found no excess MS cases or exacerbations linked to the vaccine, indicating no causal relationship.

Area of Science:

  • Epidemiology
  • Immunology
  • Neurology

Background:

  • Concerns arose regarding a potential link between the 1976 swine flu vaccine and multiple sclerosis (MS).
  • Previous analyses did not establish an association between vaccination and MS onset or exacerbations.

Purpose of the Study:

  • To estimate the number of new multiple sclerosis cases following swine flu vaccination.
  • To investigate potential associations between swine flu vaccination and MS incidence or exacerbations.

Main Methods:

  • Utilized age-specific rates from national surveys to estimate expected MS cases in vaccine recipients.
  • Analyzed hospital admission data before, during, and after the swine flu immunization program.
  • Reviewed findings from three independent controlled clinical trials comparing vaccine and placebo groups.

Main Results:

  • An estimated 1,624 new multiple sclerosis cases were expected among 45 million swine flu vaccine recipients.
  • No excess frequency of MS cases or exacerbations was observed compared to expected rates or placebo groups.
  • Analyses of US Army hospitals and Mayo Clinic data showed no increase in MS admissions.

Conclusions:

  • The 1976 swine flu vaccine is not implicated as an etiologic factor in the onset or exacerbation of multiple sclerosis.
  • Epidemiological data and clinical investigations indicate no association or cause-and-effect relationship between swine flu vaccine and MS.

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...